Given the central role of BDNF in neuronal survival and plasticity, targeted interventions to enhance the BDNF/TrkB system could provide a promising avenue for slowing disease progression and ameliorating symptoms in HD patients. This evidence concerns the gene NTRK2 and Huntington disease.